In an interview during ASH 2025, Ontada's Ira Zackson, MD explores the role of BTK inhibitors in chronic lymphocytic leukemia ...
On January 7, 2026, Curis entered into a private placement securities purchase agreement with healthcare-focused institutional investors and company insiders for a PIPE financing structured around 20, ...
Leonardo DiCaprio wasn't thrilled over Nikki Glaser roasting his girlfriend. In her 2026 Golden Globes monologue, the ...
Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...
Dr. Thejus Jayakrishnan sat down with CURE at the 2026 ASCO Gastrointestinal Cancers Symposium to discuss research he ...